Media-OutReach Newswire AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine
Media-OutReach Newswire YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility from European Union GMP
Media-OutReach Newswire Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Media-OutReach Newswire Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Media-OutReach Newswire Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Media-OutReach Newswire Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Media-OutReach Newswire Good business performance gives Boehringer Ingelheim tailwind for investment in R&D